These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
350 related items for PubMed ID: 9701099
1. A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori. Fennerty MB, Kovacs TO, Krause R, Haber M, Weissfeld A, Siepman N, Rose P. Arch Intern Med; ; 158(15):1651-6. PubMed ID: 9701099 [Abstract] [Full Text] [Related]
2. Triple versus dual therapy for eradicating Helicobacter pylori and preventing ulcer recurrence: a randomized, double-blind, multicenter study of lansoprazole, clarithromycin, and/or amoxicillin in different dosing regimens. Schwartz H, Krause R, Sahba B, Haber M, Weissfeld A, Rose P, Siepman N, Freston J. Am J Gastroenterol; 1998 Apr; 93(4):584-90. PubMed ID: 9576452 [Abstract] [Full Text] [Related]
3. [Treatment of Helicobacter pylori infection with lansoprazole 30 mg or 60 mg combined with two antibiotics for duodenal ulcers]. Lamouliatte H, Perie F, Joubert-Collin M. Gastroenterol Clin Biol; 2000 May; 24(5):495-500. PubMed ID: 10891736 [Abstract] [Full Text] [Related]
4. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country. Ahuja V, Dhar A, Bal C, Sharma MP. Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815 [Abstract] [Full Text] [Related]
5. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M, Sugiyama T, Kato M, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S. Helicobacter; 2001 Sep; 6(3):254-61. PubMed ID: 11683930 [Abstract] [Full Text] [Related]
6. Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group. Harris AW, Misiewicz JJ, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D. Aliment Pharmacol Ther; 1998 Aug; 12(8):741-5. PubMed ID: 9726387 [Abstract] [Full Text] [Related]
7. Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study. Wong BC, Xiao SD, Hu FL, Qian SC, Huang NX, Li YY, Hu PJ, Daldiyono, Manan C, Lesmana L, Carpio RE, Perez JY, Fock KM, Kachintorn U, Phornphutkul K, Kullavanijaya P, Ho J, Lam SK. Aliment Pharmacol Ther; 2000 Feb; 14(2):217-24. PubMed ID: 10651663 [Abstract] [Full Text] [Related]
8. Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection. Harford W, Lanza F, Arora A, Graham D, Haber M, Weissfeld A, Rose P, Siepman N. Helicobacter; 1996 Dec; 1(4):243-50. PubMed ID: 9398875 [Abstract] [Full Text] [Related]
9. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E. Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980 [Abstract] [Full Text] [Related]
10. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Luzza F, Giglio A, Ciliberto E, Belmonte A, Cavaliere C, Saccà N, Frandina C, Fiocca R, Trimboli V, Pallone F. Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734 [Abstract] [Full Text] [Related]
11. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Asaka M, Kato M, Sugiyama T, Satoh K, Kuwayama H, Fukuda Y, Fujioka T, Takemoto T, Kimura K, Shimoyama T, Shimizu K, Kobayashi S, Japan Helicobacter pylori Eradication Study Group. J Gastroenterol; 2003 May; 38(4):339-47. PubMed ID: 12743773 [Abstract] [Full Text] [Related]
12. Can lansoprazole, amoxicillin, and clarithromycin combination still be used as a first-line therapy for eradication of helicobacter pylori? Güliter S, Keleş H, Ozkurt ZN, Cengiz DU, Kolukisa E. Turk J Gastroenterol; 2005 Mar; 16(1):29-33. PubMed ID: 16252185 [Abstract] [Full Text] [Related]
13. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin. Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN. Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531 [Abstract] [Full Text] [Related]
14. Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study). Di Mario F, Battaglia F, Dal Bò N, Leandro G, Benedetti E, Bottona E, Caroli A, Costan-Biedo F, De Bastiani R, Germanà B, Andrea Grassi S, Madia D, Marcon V, Marin R, Monica F, Olivieri P, Orzes N, Pilotto A, Ronzani G, Saggioro A, Tafner G. Dig Liver Dis; 2000 Mar; 32(2):108-15. PubMed ID: 10975783 [Abstract] [Full Text] [Related]
15. Twice-daily, 10-day triple therapy with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in duodenal ulcer disease: results of three multicenter, double-blind, United States trials. Laine L, Suchower L, Frantz J, Connors A, Neil G. Am J Gastroenterol; 1998 Nov; 93(11):2106-12. PubMed ID: 9820381 [Abstract] [Full Text] [Related]
16. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Misiewicz JJ, Harris AW, Bardhan KD, Levi S, O'Morain C, Cooper BT, Kerr GD, Dixon MF, Langworthy H, Piper D. Gut; 1997 Dec; 41(6):735-9. PubMed ID: 9462204 [Abstract] [Full Text] [Related]